Navigating the EU's Sweeping REACH Requirements: Nov. 30 Deadline Could Affect your Ability to Do Business
$427.00
Product Details
In this 90-minute Encore presentation, European legal experts Cándido García Molyneux and Peter Bogaert will take attendees step-by-step through the new regulation and advise them on how to determine if their products require registration under the five categories related to drug and medical devices.
Sign up your entire team to listen in and discover:
- The REACH regulation’s potential impact on drug and device companies
- How best to determine if your products or source materials meet the requirements for registration
- What substances can be registered in accordance with the European Inventory of Existing Commercial Substances
- Who can preregister and the procedures for doing so
- Why a company should preregister and what the penalties are if they don’t
- Best practices for selecting and working with a European representative
- The potential usefulness of trade association consortia
- The various methods for calculating volumes and what level of information must be provided
This presentation includes detailed instructions on how to comply with the preregistration requirements in order for firms to be assured that they can continue to operate in the EU. In addition, the speakers will provide insight into what level of technical detail is required to comply with the regulations.
Register now and you'll get an opportunity to ask your toughest questions during the Q&A session.